tomatidine has been researched along with tetradecanoylphorbol acetate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Jeon, S; Kim, MM | 1 |
2 other study(ies) available for tomatidine and tetradecanoylphorbol acetate
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Tomatidine inhibits cell invasion through the negative modulation of gelatinase and inactivation of p38 and ERK.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Movement; Cell Nucleus; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Free Radical Scavengers; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Tetradecanoylphorbol Acetate; Tomatine; Transcription Factor AP-1; Vascular Endothelial Growth Factor A | 2019 |